Article Text

Download PDFPDF
IDDF2024-ABS-0338 Mas1 deficiency protects against acute liver failure by suppressing the FXR/S1P/Raf-dependent NETosis in mice
  1. Bo Yang,
  2. Jing Li,
  3. Changqing Yang
  1. Shanghai Tongji Hospital, China

Abstract

Background Mas is a newly discovered G protein-coupled receptor that plays a critical role in inflammatory responses. The gut-liver axis regulates neutrophilic inflammation, which is crucial in acute liver failure (ALF); however, the underlying mechanisms remain poorly understood. The aim of this study is to investigate Mas signaling and neutrophilic inflammation in ALF and to elucidate its underlying mechanisms.

Methods The 8-10 week-old male Mas1 -/-, Vil1 cre Mas1 f/f, and wild-type control mice were subjected to intraperitoneal challenge with D-galactosamine/lipopolysaccharide(D/L) for in vivo analysis of the gut-liver axis-dependent formation of neutrophil extracellular traps (NET), utilizing pharmacological compounds and genetic tools. Age-matched mice received injections of phosphate-buffered saline as vehicle controls.

Results The hepatic and ileal expression of Mas was significantly upregulated in ALF patients and mice models (IDDF2024-ABS-0338 Figure 1. The hepatic and ileal expression of Mas1 in D/L-induced ALF mice). The knockout of the Mas1 gene in both systemic and intestinal epithelial cells significantly alleviated D/L-induced NETosis and hepatotoxicity in mice (IDDF2024-ABS-0338 Figure 2. The knockout of the Mas1 gene in both systemic and intestinal epithelial cells significantly alleviated D/L-induced ALF in mice). The involvement of gut microbiota in the attenuated hepatotoxicity of Mas1 -/--D/L mice was confirmed through antibiotic experiments. The co-housed experiments between Mas1 -/- and WT mice have demonstrated that Mas1 -/- may confer protection by reducing the intestinal abundance of Eubacterium sp. and inhibiting deoxycholic acid (DCA) production (IDDF2024-ABS-0338 Figure 3. Mas1 may confer protection by reducing the intestinal abundance of Eubacterium sp and inhibiting DCA production). This was accompanied by hepatic activation of farnesoid X receptor (FXR) signaling and suppression of downstream sphingosine-1-phosphate (S1P)-dependent NETosis. As revealed by single-cell transcriptomics, the downregulation of NETosis in Mas1 -/--D/L mice was found to be dependent on the senescence of Cldn1+CD177+ neutrophils and the activation of Raf signaling (IDDF2024-ABS-0338 Figure 4. The downregulation of NETosis in Mas1Ko-D/L mice was found to be dependent on the senescence of Cldn1+CD177+ neutrophils and the activation of Raf signaling).

Abstract IDDF2024-ABS-0338 Figure 1

The hepatic and ileal expression of Mas1 in D/L-induced ALF mice

Abstract IDDF2024-ABS-0338 Figure 2

The knockout of the Mas1 gene in both systemic and intestinal epithelial cells significantly alleviated D/L-induced ALF in mice

Abstract IDDF2024-ABS-0338 Figure 3

Mas1 may confer protection by reducing the intestinal abundance of Eubacterium sp and inhibiting DCA production

Abstract IDDF2024-ABS-0338 Figure 4

The downregulation of NETosis in Mas1Ko-D/L mice was found to be dependent on the senescence of Cldn1+CD177+ neutrophils and the activation of Raf signaling

Conclusions Mas1 -/- significantly protects mice from D/L-induced hepatotoxicity by suppressing the FXR/S1P/Raf-dependent NETosis, thereby suggesting Mas as a promising therapeutic target for ALF.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.